Jason Alger
CIK: 0001839111
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Health Catalyst, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 1, 2026HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct18K shares at avg. $1.70$31K - Jun 1, 2026HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct18.8K shares at avg. $1.37$26K - Mar 2, 2026HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct27K shares at avg. $1.66$45K - Feb 26, 2026HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct7.5K shares at avg. $1.75$13K - Feb 25, 2026HCAT
Health Catalyst, Inc.
Award(A)Direct22.2K shares- - Feb 25, 2026HCAT
Health Catalyst, Inc.
Award(A)Direct507.5K shares- - Dec 1, 2025HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct20.6K shares at avg. $2.90$60K - Sep 2, 2025HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct2.6K shares at avg. $3.36$9K - Jun 2, 2025HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct2.7K shares at avg. $3.63$10K - Mar 3, 2025HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct7.3K shares at avg. $4.58$33K - Feb 20, 2025HCAT
Health Catalyst, Inc.
Award(A)Direct12K shares- - Feb 20, 2025HCAT
Health Catalyst, Inc.
Award(A)Direct181K shares- - Dec 6, 2024HCAT
Health Catalyst, Inc.
Sale(S)Direct19.6K shares at avg. $8.32$163K - Dec 1, 2024HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct7.8K shares at avg. $8.97$70K - Sep 6, 2024HCAT
Health Catalyst, Inc.
Sale(S)Direct2.9K shares at avg. $7.39$21K - Sep 3, 2024HCAT
Health Catalyst, Inc.
Tax Payment(F)Direct1.2K shares at avg. $7.27$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 17,973 | $1.70 | $30,619 | Direct |
| Jun 1, 2026 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 18,804 | $1.37 | $25,765 | Direct |
| Mar 2, 2026 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 26,970 | $1.66 | $44,768 | Direct |
| Feb 26, 2026 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 7,522 | $1.75 | $13,147 | Direct |
| Feb 25, 2026 | HCAT Health Catalyst, Inc. | Award(A) | 22,222 | - | $0 | Direct |
| Feb 25, 2026 | HCAT Health Catalyst, Inc. | Award(A) | 507,500 | - | $0 | Direct |
| Dec 1, 2025 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 20,619 | $2.90 | $59,799 | Direct |
| Sep 2, 2025 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 2,613 | $3.36 | $8,787 | Direct |
| Jun 2, 2025 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 2,712 | $3.63 | $9,858 | Direct |
| Mar 3, 2025 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 7,304 | $4.58 | $33,431 | Direct |
| Feb 20, 2025 | HCAT Health Catalyst, Inc. | Award(A) | 11,950 | - | - | Direct |
| Feb 20, 2025 | HCAT Health Catalyst, Inc. | Award(A) | 181,000 | - | - | Direct |
| Dec 6, 2024 | HCAT Health Catalyst, Inc. | Sale(S) | 19,599 | $8.32 | $163,050 | Direct |
| Dec 1, 2024 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 7,795 | $8.97 | $69,946 | Direct |
| Sep 6, 2024 | HCAT Health Catalyst, Inc. | Sale(S) | 2,899 | $7.39 | $21,427 | Direct |
| Sep 3, 2024 | HCAT Health Catalyst, Inc. | Tax Payment(F) | 1,165 | $7.27 | $8,469 | Direct |
1-16 of 16 transactions
About Alger Jason
Alger Jason (SEC CIK 0001839111) files insider reports with the SEC as Chief Financial Officer of Health Catalyst, Inc. (HCAT).
Signal8 holds 13 ownership filings by Alger Jason, all Form 4s, filed between Sep 5, 2024 and Sep 3, 2026. Those filings report 16 transactions, from Sep 3, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Alger Jason's filings is in SOUTH JORDAN, UT.
Recent filings by Alger Jason
- Sep 1, 2026: Tax withholding of HCAT shares (Form 4, code F).
- Jun 1, 2026: Tax withholding of HCAT shares (Form 4, code F).
- Mar 2, 2026: Tax withholding of HCAT shares (Form 4, code F).
- Feb 26, 2026: Tax withholding of HCAT shares (Form 4, code F).
- Feb 25, 2026: Grants or awards of HCAT shares (2 lines, Form 4, code A).
Other insiders filing for Health Catalyst, Inc. (HCAT)
- Reller Tami, Director
- Kohl Simeon, Chief Executive Officer
- Albert Benjamin, CEO
- Larson-Green Julie, Director
- Landry Benjamin, General Counsel
- Hoggard Green Jill, Director